Original Study| Volume 14, ISSUE 4, e341-e346, August 2016

Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience

Published:December 23, 2015DOI:



      Previous studies showed high hospital readmission rates after radical cystectomy (RC) for bladder cancer (BCa), however at the time results of a European series analyzing this event were still missing.

      Patients and Methods

      Overall, 1090 consecutive BCa patients treated with RC at a single center between January 2002 and August 2012 were identified. Logistic regression analyses were used to test the association between covariates and 30-day readmission in the overall population and after stratifying according age at the time of surgery.


      Mean length of stay (LOS) was 19 days (median, 16 days), and the overall 30-day readmission rate was 12.2%. The most frequent reasons for readmission at 30 days were ileus (n = 15; 11.3%), lymphoceles (n = 11; 8.3%), wound infection (n = 10; 7.5%), and fever (n = 12; 9.0%). In multivariable logistic regression analysis, age (odds ratio [OR], 1.02; P = .04) and LOS (OR, 0.94; P < .01) were associated with 30-day readmission. However, when analyzed according age at the time of surgery, a beneficial effect from a longer LOS was observed only in patients older than 70 years (P < .003).


      In the first European series on the effect of 30-day readmission, our data showed that even with a relative high mean LOS, 30-day readmission remained an ineradicable factor. Of note, older patients and shorter LOS were associated with an increased risk of readmission at 30 days, however, an increase of LOS to prevent readmission seemed effective only in patients older than 70 years.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Witjes J.A.
        • Compérat E.
        • Cowan N.C.
        • et al.
        EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.
        Eur Urol. 2014; 65: 778-792
        • Hollenbeck B.K.
        • Miller D.C.
        • Taub D.
        • et al.
        Identifying risk factors for potentially avoidable complications following radical cystectomy.
        J Urol. 2005; 174 (discussion 1237): 1231-1237
        • Shabsigh A.
        • Korets R.
        • Vora K.C.
        • et al.
        Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.
        Eur Urol. 2009; 55: 164-174
        • Kim S.P.
        • Shah N.D.
        • Karnes R.J.
        • et al.
        The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer.
        J Urol. 2012; 187: 2011-2017
        • Novara G.
        • De Marco V.
        • Aragona M.
        • et al.
        Complications and mortality after radical cystectomy for bladder transitional cell cancer.
        J Urol. 2009; 182: 914-921
        • Jencks S.F.
        • Williams M.V.
        • Coleman E.A.
        Rehospitalizations among patients in the Medicare fee-for-service program.
        N Engl J Med. 2009; 360: 1418-1428
        • Vest J.R.
        • Gamm L.D.
        • Oxford B.A.
        • Gonzalez M.I.
        • Slawson K.M.
        Determinants of preventable readmissions in the United States: a systematic review.
        Implement Sci. 2010; 5: 88
        • Feigenbaum P.
        • Neuwirth E.
        • Trowbridge L.
        • et al.
        Factors contributing to all-cause 30-day readmissions: a structured case series across 18 hospitals.
        Med Care. 2012; 50: 599-605
      1. Hospital Readmissions Reduction Program, C. for M. & M., Available at:, S. & Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html. Accessed: January 16, 2016.

        • Aghazadeh M.A.
        • Barocas D.A.
        • Salem S.
        • et al.
        Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.
        J Urol. 2011; 1285: 85-89
        • Jacobs B.L.
        • Zhang Y.
        • Tan H-J.
        • Ye Z.
        • Skolarus T.A.
        • Hollenbeck B.K.
        Hospitalization trends after prostate and bladder surgery: implications of potential payment reforms.
        J Urol. 2013; 189: 59-65
        • Skolarus T.A.
        • Jacobs B.L.
        • Schroeck F.R.
        • et al.
        Understanding readmission intensity after radical cystectomy.
        J Urol. 2015; 193: 1500-1506
        • Hu M.
        • Jacobs B.L.
        • Montgomery J.S.
        • et al.
        Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer.
        Cancer. 2014; 120: 1409-1416
        • Harraz A.M.
        • Osman Y.
        • El-Halwagy S.
        • et al.
        Risk factors of hospital readmission after radical cystectomy and urinary diversion: analysis of a large contemporary series.
        BJU Int. 2015; 115: 94-100
        • Stimson C.J.
        • Chang S.S.
        • Barocas D.A.
        • et al.
        Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series.
        J Urol. 2010; 184: 1296-1300
        • Pak J.S.
        • Lascano D.
        • Kabat D.H.
        • et al.
        Patterns of care for readmission after radical cystectomy in New York State and the effect of care fragmentation.
        Urol Oncol. 2015; 33: 426.e13-426.e19
        • Taub D.A.
        • Dunn R.L.
        • Miller D.C.
        • Wei J.T.
        • Hollenbeck B.K.
        Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care.
        J Urol. 2006; 176 (discussion 2617-8): 2612-2617
        • Edge S.B.
        • Compton C.C.
        The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.
        Ann Surg Oncol. 2010; 17: 1471-1474
        • Gore J.L.
        • Lai J.
        • Gilbert S.M.
        Readmissions in the postoperative period following urinary diversion.
        World J Urol. 2011; 29: 79-84